← SynDRA
MRS-1220
SynDRA canonical compound SYN1969098 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADORA2B | ADORA3 |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- adenosine receptor antagonist
Cross-references
Synonyms
- MRS 1220
- CHEMBL88147
- N-(9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide
- MRS1220
- N-[9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-2-phenylacetamide
- MRS 1200
- NSC-695674
- Tocris-1217
- MRS 1220, solid
- AC1Q3QZX
- 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline
- GTPL448
- SCHEMBL927261
- AC1L96H4
- CTK8F0085
- CHEBI:92667
- MolPort-003-958-674
- ZINC602092
- HMS3267D09
- NSC695674
- BDBM50053929
- AKOS024456471
Look up MRS-1220 in the interactive SynDRA portal →